Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

The Prize-winners are universities and colleges who have been recognised for ground-breaking work and pioneering research in a wide range of disciplines including science, engineering, education, the humanities, the environment and medicine. 

Among those honoured was Oxford University whose efforts delivered vitally important design and creation of a COVID-19 vaccine. This work was notably completed at an unprecedented speed and helped reduce loss of life worldwide from coronavirus.

In a period where COVID-19 and climate change have become the most prominent issues of our time, the final list of Prize-winners reflects the strong contribution of universities and colleges in these areas. 

Patrick Grant, Pro Vice Chancellor (Research) Oxford University said, 'Oxford tackled COVID-19 using all of our capabilities to understand and fight the pandemic. We worked across all disciplines, departments and teams to develop vaccines, to repurpose drugs, to support the prediction of future outbreaks, to inform public health and to develop diagnostic tools.'

He added, 'This prestigious award is a testament to the dedication, resilience and commitment of Oxford University’s research students and research staff at all career stages. We can all be proud of our efforts and achievements during a very difficult time.’

Read the full story on the University of Oxford website.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.